Talk of financial reform is prompting investors to flee shares of the CME Group and NYSE Euronext—despite evidence that new rules could help the exchanges
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.